MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Moleculin Biotech, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.27−0.02 (-5.49%)
Close on Oct 19, 2026
- Market cap
- $1.51M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Oct 20, 2026 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Mar 18, 2026(first seen in filings) | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Dec 1, 2025 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Mar 22, 2024 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Mar 22, 2024(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Mar 24, 2021(first seen in filings) | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |
| Feb 1, 2021 | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |